Active DNA demethylation occurs after a sperm enters an egg. However, the mechanisms for the active DNA demethylation remain poorly understood. Ten-eleven translocation enzymes were recently shown to catalyze the conversion of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC). Thus, we decided to investigate the role of 5hmC in active demethylation. We analyzed the methylation and hydroxymethylation status in metaphase II oocytes as well as 1-cell stage and cleavage stage embryos. In zygotes, 5hmC was mainly detected in the paternal pronucleus and it increased from the pronuclear-2 (PN2) to PN5 stages, an indication that 5hmC was involved in paternal genomic DNA demethylation. Bisulfite-sequencing PCR and qGluMS-PCR (DNA glucosylation and digestion before quantitative PCR) results showed that a large reduction of methylcytosine and hydroxymethylcytosine in LINE1 (long interspersed nuclear element 1) occurred between the 4-and 8-cell stages, which indicates that demethylation potentially occurred after the 4-cell stage. We then microinjected mouse zygote with plasmids that were methylated in vitro by SssI methylase and analyzed for the hydroxymethylation status of the plasmids promoter region. We found that the rapid onset of expression of the unmethylated plasmids in mouse embryos happened in ,12 h, but the expression of methylated plasmids was delayed until 50 h when most embryos were at the 8-cell stage. Quantitative GluMS-PCR results suggested that 5hmC was present in the plasmid's promoter region at the MspI site where the active demethylation occurred. Our results demonstrate that 5hmC is involved in active demethylation in mice.
INTRODUCTION
DNA methylation plays an important role in the regulation of gene expression and is essential for normal mammalian development [1, 2] . Genome-wide DNA methylation changes have been observed during at least two stages of mouse embryogenesis. The first event occurs during early development of mouse embryos after the sperm enters an egg [3, 4] while the other occurrence is in primordial germ cells, which helps to establish gender-specific methylation patterns [5] . In zygotes, the paternal genome and the maternal genome undergo different reprogramming processes. After fertilization, the paternal genome rapidly demethylates independent of genomic DNA replication; this process is called active demethylation [4] . In contrast, the maternal genome resists demethylation. During embryo cleavage, the maternal genome undergoes demethylation during DNA replication in the absence of DNA methyltransferase 1 (DNMT1) [6] .
Because the process of active demethylation is independent of DNA replication [7] , factors must exist in zygotes that promote active demethylate. Over the past three decades, many enzymes have been implicated in the process of active DNA demethylation. Despite extensive efforts, the factors responsible for active DNA demethylation have not been identified, and many of those that have been implicated remain controversial [7] [8] [9] [10] [11] [12] . 5-Hydroxymethlcytosine (5hmC), which was first discovered in mouse Purkinje and granule neurons [13, 14] , is thought to be potentially involved in active DNA demethylation. 5-Hydroxymethlcytosine is generated by oxidation of 5-methylcytosine (5mC) by the TET (ten-eleven translocation) family of enzymes, which encompasses Tet1, Tet2, and Tet3. Tet1 is highly expressed in embryonic stem (ES) cells and is essential for ES cell self-renewal [15] [16] [17] [18] . The primary sequences of Tet1 and Tet2 are very similar, and mutations of the latter that compromise its catalytic activity have been associated with myeloid malignancies [19] . Tet2 also regulates 5hmC production and cell lineage specification in mouse ES cells [18] . Tet3 is specifically expressed in oocytes and zygotes and is the most likely candidate for 5mC reduction in the paternal pronucleus [20, 21] . All three TET enzymes contain a dioxygenase motif involved in Fe (II) and aketoglutarate binding and catalytic activity and were shown to possess similar levels of activity [15, 22] .
During embryogenesis, DNA demethylation is necessary for epigenetic reprogramming [4, 23] . Although the involvement of 5mC in the regulation of gene expression is well characterized [1, [24] [25] [26] , the relationship between 5hmC and genomic DNA is poorly understood. The goal of this study was to investigate if 5hmC is involved in active DNA demethylation in mice.
MATERIALS AND METHODS

Reagents and Animals
All the reagents were purchased from Sigma unless otherwise noted. ICR mice and Kunming (KM) mice were purchased from the Experimental Animal Center of Jilin University and Changchun Hi-Tech Laboratory Animal Research Center, respectively, and housed under controlled light cycle conditions (14L:10D). Animal treatment complied with a protocol approved by the Jilin University Institutional Animal Care and Use Committee.
Six-wk-old female ICR mice were superovulated by intraperitoneal injection of 10 IU (international units) of equine chronic gonadotropin (Ningbo), followed by intraperitoneal injection of 10 IU of human chorionic gonadotropin (hCG; Ningbo) at 48 h intervals. Metaphase II (MII) oocytes were collected from the oviducts 18 h after hCG injection and were denuded from cumulus cells by treatment with 0.2% hyaluronidase. Only oocytes with a first polar body, normal morphology, and uniform cytoplasm were selected for parthenogenetic activation. After treatment with 5 mM ionomycin for 5 min at room temperature, oocytes were incubated in KSOM medium (Millipore) containing 2 mM 6-dimethylaminopurine at 5% CO 2 and 378C for 4 h. After incubation, the parthenogenetic embryos with two pronuclei were cultured in KSOM at 5% CO 2 and 378C for 1-4 days. For zygote collection, female ICR mice were mated with male KM mice at a 1:1 ratio after hCG injection, and females with vaginal plugs were used for zygote preparation. Plugged females were euthanized at Day 0.5, and zygotes were isolated and cultured in KSOM with 5% CO 2 and 378C for 1-4 days.
Immunostaining and Confocal Imaging
Metaphase II oocytes and pronuclear (PN) stage embryos were collected from female ICR mice, and the zona pellucida (ZP) was removed with 0.5% acidic Tyrode solution, pH 2.5. Embryos at different developmental stages were collected and washed in PBS containing 0.1% polyvinylpyrrolidone. Embryos were fixed in 4% paraformaldehyde for 10 min and permeabilized for 10 min with PBS containing 0.2% Triton X-100. Permeabilized embryos were denatured with 4 N HCl for 30 min at room temperature and subsequently neutralized for 10 min with 100 mM Tris-HCl buffer, pH 8.5. These embryos were blocked overnight at 48C in 2% BSA before incubation with primary antibodies, anti-5mC (1:200; Eurogentec) or anti-5hmC (1:300; Active Motif), for 2 h in a humidified chamber at 378C. After multiple consecutive 5 min washes with PBS containing 0.2% Triton X-100, embryos were incubated with secondary antibodies, Alexa Fluor 568 goat anti-mouse (1:400; Invitrogen) and Alexa Fluor 488 goat anti-rabbit (1:400; Invitrogen), for 1 h. Confocal images were acquired using an Olympus Fv100 microscope and processed using the FV10-ASW 1.7 Viewer.
Methylation of Plasmid In Vitro and Microinjection into One-Cell Stage Embryos
Two different plasmids were used: 1) a plasmid with the human elongation factor-1 alpha (pEF1A) promoter to drive the EGFP (enhanced green fluorescent protein) open reading frame (pEF1A-EGFP) or 2) a plasmid with the cytomegalovirus (pCMV) promoter to drive the RFP (red fluorescent protein) open reading frame (pCMV-tdTomato). Methylation of cytosine bases in CpG dinucleotides was accomplished with a recombinant methyltransferase (SssI; NEB). One microgram of pEF1A-EGFP was incubated with 4 U SssI in the presence of 640 lM S-adenosyl methionine, according to the manufacturer's instructions. Complete methylation was verified with the methylationsensitive restriction enzyme HpaII (NEB), and a Gel Extraction Kit (Tiangen) was used to purify the methylated plasmid. The methylated plasmid (pmEF1A-EGFP) and the unmethylated pCMV-tdTomato plasmid were mixed in a 1:1 ratio and prepared in 10 mM Tris-HCl, pH 8.0, with 0.25 mM ethylenediaminetetraacetic acid at a final concentration of 10 ng/ll. Approximately 1 pl of plasmid solution was microinjected into the pronucleus using an Eppendorf CellTram vario system (Eppendorf). The injected embryos were cultured in KSOM at 5% CO 2 and 378C and collected at various time points for methylation and gene expression analysis. Fluorescence images were acquired using a Nikon CH-M100CB-1 fluorescence microscope with Nikon ACT-1C DXM 1200C software.
Reverse Transcription PCR
Total RNA and DNA were isolated from embryos with a micro-DNA/RNA isolation kit (QIAGEN) at 0 h (n ¼ 35), 3 h (n ¼ 40), and 50 h (n ¼ 37) after methylated plasmid injection. RNA was immediately committed to reverse transcription using the RevertAid First Strand cDNA synthesis kit (Fermentas) according to the manufacturer's instructions. 
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DNA Glucosylation, Digestion, and Quantitative PCR DNA were isolated from embryos at
, and blastocysts (n ¼ 10). DNA was subjected to T4 phage bglucosyltransferase (T4-BGT) (NEB) for 18 h according to the manufacturer's instructions [27] . Glucosylated DNA was digested with 40 U of HpaII, 100 U of MspI, or no enzyme (mock digestion) at 378C for 18 h followed by treatment with proteinase K (PK) for 30 min at 408C and subsequent inactivation of PK at 988C for 10 min. HpaII-and MspI-resistant fractions were used for quantitative PCR (q-PCR) using primers that were designed around MspI and HpaII sites. Glucosylated DNA that was not completely digested by MspI at the MspI site was considered to contain 5hmC at that site. The primers that were used for q-PCR are listed in Table 1 . The real-time PCR reaction (25 ll) consisted of 2 ll of DNA, 12.5 ll of SYBR green master mix (TaKaRa), 9.5 ll of RNase-free water, and 0.5 ll of both forward and reverse primers (10 pmol) for each gene. The program used for the amplification of all the genes consisted of a denaturing cycle of 1 min at 958C and 40 cycles of PCR (958C for 15 sec, 608C for 1 min). The relative amounts of DNA were analyzed using the 2 ÀDDCT method [28] .
Bisulfite Sequencing
For bisulfite sequencing, MII oocytes and fertilized embryos were collected at different stages following hCG injection. The embryos were treated with 0.5% acidic Tyrode solution, pH 2.5, to remove the ZP and then subjected to bisulfite conversion using the EZ DNA Methylation Direct Kit (Zymo Research). PCR was performed using ExTaqHS (TaKaRa, Japan). The PCR primer sequences are listed in Table 1 .
Statistical Analysis
Data were analyzed with Statistics Production for Service Solution, version 16.0 (SPSS). Results of q-PCR were analyzed by one-way ANOVA, and chisquare analysis was used for the number of fluorescent embryos between groups. A P value ,0.05 was considered to be statistically significant.
RESULTS
Appearance of 5hmC in One-Cell Stage Embryos
Genomic methylation and hydroxymethylation were visualized with immunofluorescence (IF) staining of 5mC and 5hmC, respectively. First, we examined for the existence of 5hmC in fertilized pronuclear stage embryos. Pronuclear stages were identified as described previously [29] . Briefly, zygotes were collected from 21 to 30 h after hCG injection and assigned to PN1-PN5. Immunofluorescence showed that maternal and paternal pronuclei displayed opposing patterns of 5hmC and 5mC staining in fertilized zygotes. During the PN4 stage, the paternal pronucleus exhibited a strong IF signal 
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for 5hmC compared to the maternal pronucleus (Fig. 1 A) . At metaphase, almost half of the chromosomes demonstrated intense staining for 5hmC while the remaining chromosomes exhibited 5mC staining (Fig. 1A) . Next, parthenogenetic embryos were used to determine if 5hmC was present in genomic DNA. Immunofluorescence results showed that the two pronuclei in parthenogenetic embryos not only had 5hmC staining, but the intensity of the 5hmC and 5mC staining at the PN5 and metaphase stages were identical (Fig. 1B) . To further determine the relationship between 5mC and 5hmC, we collected sperm, MII oocytes, and embryos at defined PN stages and used their DNA for bisulfite conversion and qGluMS-PCR (DNA glucosylation and digestion before quantitative PCR) of long interspersed nuclear element 1 (LINE1). The methylation level of LINE1 was 45.6% in PN2 and decreased to 37.2% at PN5 and to 32.3% at the syngamy stage ( Fig. 2A) . The level was 87.3% and 64.6% in sperm and MII oocytes DNA, respectively ( Fig. 2A) . Quantitative GluMS-PCR showed that 5hmC:5mC in PN2 and PN5 was 24.4% and 75% (Fig. 2B) , respectively.
Existence of 5hmC in Preimplantation Embryos
To further investigate the distribution of 5hmC in cleavage stage embryos, fertilized embryos were used for IF staining. Staining for 5hmC was observed in 2-cell stage embryos (Fig.   3 , A, A ' , and A"). During the 8-cell and morula stages, 5mC staining was rarely detected within nuclei while 5hmC staining remained intense (Fig. 3, B, B ' , B", C, C ' , and C"). However, in blastocysts, 5mC and 5hmC staining was clearly visible in the inner cell mass (ICM), while the trophectoderm had weaker ZHANG ET AL. staining (Fig. 3, D, D ' , and D"). To further study the relationship between 5mC and 5hmC, bisulfite conversion and qGluMS-PCR of LINE1 were performed. In cleavage stage embryos, total methylation in LINE1 decreased, especially between the 4-to 8-cell stages (Fig. 4A) . Total CpG methylation of LINE1 at the 2-cell stage was 61.5% and remained at 65% at the 4-cell stage. However, the methylation level decreased to 37.7% in the 8-cell stage. At the morula and blastocyst stages, the methylation levels were 38% and 29.8%, respectively. The qGluMS-PCR results showed that 5hmC:5mC was 49.5% in the 2-cell stage and increased to 66% in the 4-cell stage. At the 8-cell and morula stages, the ratio was 23.1% and 20.6% (Fig. 4B) , respectively.
Involvement of 5hmC in Exogenous DNA Demethylation
To determine if the reprogramming of methylated plasmids required 5hmC, the exogenous plasmids and 1-cell stage embryos were microinjected. First, unmodified plasmids (pEF1A-EGFP and pCMV-tdTomato) were coinjected into zygotes to determine if coinjection affected fluorescent protein expression. After 12 h, EGFP and RFP expression were observed, and expression continued through the blastocyst stage (Fig. 5A) . Methylated (pmEF1A-EGFP) and unmethylated (pCMV-tdTomato) plasmids were then used for the injections. At 50 h, the expression of the EGFP protein was seen in the embryos, while the expression of the RFP protein was observed less than 12 h after the injection (Figs. 5B and 6) . To confirm the expression of the fluorescent protein, we performed RT-PCR analysis of mRNA expression in the injected embryos. As shown in Figure 7C , mRNA expression of Rfp was observed at 3 h and 50 h after plasmids injection, but the expression of EGFP was only observed at 50 h. The reprogramming capability of methylated plasmid by fertilized and parthenogenetic embryos was also compared. After methylated plasmid was microinjected into fertilized embryos, we found relatively fewer EGFP-positive embryos (30.1%) compared to embryos with unmodified plasmid (98.3%) ( Table  2 ). After injection of parthenogenetic embryos with methylated plasmid, EGFP expression was observed in 4.8% of the embryos (Table 2) . When we examined EGFP-positive embryos after the injection of methylated plasmid, we found that most of the embryos displayed a mosaic EGFP expression in fertilized (93.6%) and parthenogenetic embryos (100%). However after unmodified plasmid injection, mosaic embryos were seen in only 3.5% of the total (Table 2 ). To determine whether 5hmC was present in the promoter region of the methylated plasmid, we performed glucosylation of 5hmC in DNA followed by MspI digestion and PCR across the MspI sites [16] . Verification of T4-BGT and of SssI was also performed (Fig. 7, A and B, respectively) . For plasmid recovery, embryos were collected at 0 h and 50 h after injection, and the DNA was extracted. Using qRT-PCT and end-point PCR, we were able to detect the presence of 5hmC in 
FIG. 7.
Analysis of 5hmC in the promoter region of plasmid. A) To verify the effectiveness of T4-BGT, 5mC control DNA, 5hmC control DNA, and unmodified control DNA (supplied with the T4-BGT) were mixed in a 1:1:1 ratio and then subjected to glucosylation and digestion. The digested products were treated with proteinase K and used for real-time PCR. B) To verify the effectiveness of methyltransferase, the methylated plasmid (lane 1) and unmodified plasmid (lane 2) were digested with HpaII after treatment with methyltransferase and then separated by gel electrophoresis. C) The mRNA expression of Rfp and Egfp at 3 and 50 h after injection. D) DNA that was not completely digested by MspI (lane 2) after glucosylation treatment but was completely digested by MspI (lane 4) without glucosylation treatment was considered to contain 5hmC at the MspI site. M, methylated plasmids injection; U, unmodified plasmids injection. E) Quantitative RT-PCR was used for further analysis.
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the promoter of pmEF1A-EGFP at 50 h after injection. At 50 h, the methylation and hydroxymethylation level was 61% and 17%, respectively. However, at 50 h, we found that unmodified plasmid became methylated at the MspI site, but no 5hmC was detected at this site (Fig. 7D) .
DISCUSSION
Upon fertilization, the paternal and maternal genomes undergo a vast amount of reprogramming, including alterations in DNA methylation and histone acetylation [30, 31] . The rapid reduction of 5mC in zygotes and the conversion of 5mC to 5hmC by TET enzymes prompted us to study whether 5hmC is involved in paternal genomic active demethylation. Our IF results showed that 5hmC was mainly present in the paternal pronucleus, which was similar to findings reported elsewhere [20, 21, 32] . In contrast to fertilized zygotes, parthenogenetic embryos, which have no involvement with the paternal genome, displayed the same intensity of 5hmC and 5mC staining. Because methylation analysis via bisulfite conversion does not easily distinguish between 5mC and 5hmC [33, 34] , we examined total 5mC and 5hmC content in LINE1 using bisulfite-sequencing PCR (BSP). DNA replication in mouse zygotes starts around the late PN3 or early PN4 stage, so PN2 stage DNA (i.e., before DNA replication) and PN5 stage DNA (i.e., after DNA replication) were used for the BSP analysis. BSP demonstrated that the development of paternal DNA demethylation corresponded with a decrease in the total amount of 5mC and 5hmC in LINE1. Most of the 5mC and 5hmC could be further converted into cytosine in LINE1, which is not in agreement with findings in a previous study [20] . In fertilized embryos, total DNA derived from MII oocytes and sperm DNA displayed changes in methylation (MII oocytes: 64.6%, sperm: 87.3%, and PN2: 45.6%) owing to active demethylation before DNA replication. After DNA replication, changes in DNA methylation (PN2: 45.6% vs. PN5: 37.2%) might be attributed to DNA replication by passive demethylation. Using GluMS-PCR, we found that 5hmC:5mC in LINE1 increased from PN2 to PN5 in fertilized zygotes, indicating that 5hmC does indeed increase in PN5 genomic DNA. Collectively these results suggest that 5hmC is involved in the demethylation of paternal genomic DNA.
In cleavage stage embryos, a passive demethylation process was thought to reduce 5mC content in maternal genomic DNA during DNA replication [35] . Immunofluorescence results showed that 5hmC was found in 2-cell stage embryos. The total 5hmC and 5mC of LINE1 in the 2-cell stage embryo was 61.5%, which was higher than that found in the syngamy stage. It seems that the 5hmC and 5mC were de novo generated during the 2-cell stage. From the 2-cell to blastocyst stages, the total 5mc and 5hmc as well as 5hmC:5mC decreased in LINE1, especially between the 4-cell to 8-cell stages. Thus, after the 4-cell stage, a demethylation process in LINE1 potentially occurred. Previously, it was shown that 5hmC prevented DNMT1 methylation of the target cytosine and interfered with maintaining methylation during cell division [36] , indicating that the presentation of 5hmC is perhaps related to gene expression. In blastocysts, de novo 5mC and 5hmC staining was clearly visible in the ICM, which was consistent with the observation that ES cells have substantial levels of 5hmC [37] . These results indicate that methylation and demethylation coexist in cleavage stage embryos and are dynamic processes.
DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei [38] , and our previous research suggested that somatic cell nuclei can be reprogrammed by oocytes [39, 40] . Therefore, we determined (23) 21 (25) 10 ( pmEF1A-EFGP * The data were analyzed using a chi-square test.
a-c Different superscript letters within the same column express significant differences, P , 0.05.
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whether or not hypermethylated plasmid DNA can be demethylated in zygotes. After the microinjection of methylated plasmids, the expression of EGFP was followed. Cytosine methylation of gene promoter regions usually inhibits gene expression [41] ; as a result, the plasmid is incapable of replicating in the cells [42] . Thus, expression of EGFP is indicative of an active demethylation process. Fifty hours after microinjection when most of embryos were at the 8-cell stage, transcription and translation of the methylated plasmid was observed. No EGFP expression was observed before 36 h, which suggested that methylated plasmid initiated translation 36 h after the microinjection. After the injection of methylated plasmid, the expression of EGFP in fertilized embryos was significantly higher than in parthenogenetic embryos (30.1% vs. 4.8%, P , 0.05), which indicates that there were differences in translation intensity between the embryos. In addition, after the injection of methylated plasmid, mosaic EGFP expression was observed, indicating that active DNA demethylation only occurred in part of the blastomere. Collectively, these results suggest that completely active demethylation of plasmid occurs after the 1-cell stage, potentially during the 2-cell stage or later.
To further investigate the involvement of 5hmC in this process, we searched for the existence of 5hmC in the promoter region of methylated plasmid using qGluMS-PCR. Quantitative GluMS-PCR showed that 5hmC appeared in the promoter region of methylated plasmid while unmodified plasmid had no 5hmC. Fifty hours after injection, the unmodified plasmid became methylated at the MspI site, but no 5hmC was detected at this site. The 5mC that was detected in the unmodified plasmid was the consequence of remethylation in the embryos [43] . Our results suggest that the demethylation and remethylation process occurs after microinjection and the conversion of 5mC to cytosine requires 5hmC.
Recent studies reported that 5hmC was further converted to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) by TET oxidation [44] [45] [46] and that the removal of 5hmC, 5fC, and 5caC was a replication-dependent pattern in mouse preimplantation embryos [47] . However our study demonstrated that the demethylation of a specific sequence such as LINE1 in the genome and exogenous DNA is a replication-independent event and that 5hmC is indeed involved in this process.
